| P2093 | author name string | Li Yang | |
| | Jia Hu | |
| | Xiang Chen | |
| | Li Wan | |
| | Chunyu Wang | |
| | Hong Luo | |
| | Aihua Peng | |
| | Lijuan Chen | |
| | Yuquan Wei | |
| | Haoyu Ye | |
| | Jianhong Yang | |
| | Qiang Qiu | |
| | Ximing Shao | |
| | Wenshuang Wu | |
| | Chengjian Zhao | |
| | Afu Fu | |
| | Heying Pei | |
| | Hansuo Yang | |
| | LuLu Chai | |
| P2860 | cites work | Rac and Rho GTPases in cancer cell motility control | Q21245504 |
| | TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways | Q89700432 |
| | Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity | Q24648175 |
| | Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis | Q24669763 |
| | Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo | Q28180577 |
| | Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production | Q28185379 |
| | VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 |
| | Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography | Q28283348 |
| | Dissemination and growth of cancer cells in metastatic sites | Q29555846 |
| | The microenvironment of the tumour-host interface | Q29620375 |
| | Epirubicin, cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma | Q33412612 |
| | Antimicrobial Activity of Phenolic Constituents of Magnolia Grandiflora L | Q34284380 |
| | Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis | Q34615993 |
| | The prognostic molecular markers in hepatocellular carcinoma | Q34668320 |
| | The cell surface: the stage for matrix metalloproteinase regulation of migration | Q34858318 |
| | Metastasis suppressors alter the signal transduction of cancer cells | Q35037682 |
| | Translational strategies for cancer prevention in liver. | Q35118721 |
| | Role of the PI3K regulatory subunit in the control of actin organization and cell migration | Q36366957 |
| | Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. | Q36496451 |
| | Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study | Q37153412 |
| | Recent advances in the natural history of hepatocellular carcinoma | Q37178623 |
| | The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment | Q37595291 |
| | Conserved F-actin dynamics and force transmission at cell adhesions | Q37781561 |
| | Why does cancer therapy lack effective anti-metastasis drugs? | Q38051530 |
| | Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes | Q38903877 |
| | Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. | Q39500189 |
| | Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model | Q39883496 |
| | Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells | Q39896830 |
| | Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models | Q39969746 |
| | Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction | Q40012007 |
| | Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma | Q40076871 |
| | Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro | Q43814720 |
| | Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells | Q43990741 |
| | Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity | Q46949401 |
| | Two antiplatelet agents from Magnolia officinalis. | Q47379482 |
| | Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases. | Q50522226 |
| | Studies on Inhibitors of Skin Tumor Promotion, IX. Neolignans from Magnolia officinalis | Q53499070 |
| | Extrahepatic Metastases of Hepatocellular Carcinoma | Q56172243 |
| | Hepatocellular carcinoma | Q57696098 |
| | Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects | Q71153875 |
| | Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells | Q77672276 |
| | Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway | Q80243492 |
| | Therapeutic targeting of the tumor microenvironment | Q81839382 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 915-932 | |
| P577 | publication date | 2016-11-29 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways | |
| P478 | volume | 8 | |